Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm

Ophthalmic Surg. 1990 May;21(5):335-8.

Abstract

From April 1983 to April 1988, 381 botulinum toxin injections for lid spasms were administered to 106 patients. Sixty-nine had bilateral blepharospasm and 37 had hemifacial spasm. Of the 381 injections, 308 had been given to patients who returned for follow-up examinations. No systemic effects were noted at any of these visits; all side effects were temporary; there were no serious complications. Ptosis, the most frequently encountered problem, occurred after 26 (8.4%) of the injections. Other complications included: corneal exposure (after eight injections, 2.59%); face droop (after 11 injections, 3.57%); diplopia (after five injections, 1.62%); and subtle visual blurring (after eight injections, 2.59%). One patient noted jaw tenseness, another mentioned tearing, one reported brow droop, and another complained of crossed eyes. Ten injections had minimal effect; in these cases a repeat injection usually was effective. Only four patients chose surgery after beginning injections. We conclude that botulinum toxin injections are a safe, effective means of treating lid spasms.

MeSH terms

  • Adolescent
  • Blepharoptosis / chemically induced
  • Blepharospasm / drug therapy*
  • Botulinum Toxins / adverse effects*
  • Botulinum Toxins / therapeutic use
  • Diplopia / chemically induced
  • Dry Eye Syndromes / chemically induced
  • Eyelid Diseases / drug therapy*
  • Facial Muscles / drug effects*
  • Female
  • Humans
  • Male
  • Prognosis
  • Spasm / drug therapy*
  • Vision Disorders / chemically induced

Substances

  • Botulinum Toxins